Serious flaws in the way the National Institute for Health and Clinical Excellence (NICE) reached its controversial decision to restrict access to dementia drugs on the NHS was submitted to the high court on 27 April, 2006 by the Alzheimer's Society. [click link for full article]
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.